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Summary
The extraocular fibrosis syndromes are congenital oc-
ular-motility disorders that arise from dysfunction of the
oculomotor, trochlear, and abducens nerves and/or the
muscles that they innervate. Each is marked by a specific
form of restrictive paralytic ophthalmoplegia with or
without ptosis. Individuals with the classic form of con-
genital fibrosis of the extraocular muscles (CFEOM1)
are born with bilateral ptosis and a restrictive infraduc-
tive external ophthalmoplegia. We previously demon-
strated that CFEOM1 is caused by an autosomal dom-
inant locus on chromosome 12 and results from a
developmental absence of the superior division of the
oculomotor nerve. We now have mapped a variant of
CFEOM, exotropic strabismus fixus (“CFEOM2”). Af-
fected individuals are born with bilateral ptosis and re-
strictive ophthalmoplegia with the globes “frozen” in
extreme abduction. This autosomal recessive disorder is
present in members of three consanguineous Saudi Ara-
bian families. Genetic analysis of 70 individuals (20 af-
fected individuals) reveals linkage to markers on chro-
mosome 11q13, with a combined LOD score of 12.3 at
the single nonrecombinant marker, D11S1314. The 2.5-
cM CFEOM2 critical region is flanked by D11S4196/
D11S4162 and D11S4184/1369. Two of the three fam-
ilies share a common disease-associated haplotype, sug-
gesting a founder effect for CFEOM2. We hypothesize
that CFEOM2 results from an analogous developmental
defect to CFEOM1, one that affects both the superior
and inferior divisions of the oculomotor nerve and their
corresponding alpha motoneurons and extraocular
muscles.
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Introduction
The extraocular fibrosis syndromes are congenital ocu-
lar-motility disorders that arise from dysfunction of the
oculomotor, trochlear, and abducens nerves and/or the
muscles that they innervate. The syndromes include
Duane syndrome (MIM 126800) and congenital fibrosis
of the extraocular muscles (CFEOM); each syndrome is
manifested clinically by a specific form of restrictive par-
alytic ophthalmoplegia with or without ptosis (Brown
1950; Harley et al. 1978). Duane syndrome is typically
sporadic, and affected individuals are born with re-
stricted adduction and/or abduction with globe retrac-
tion on attempted adduction (Huber 1984). Two neu-
ropathological studies of Duane syndrome found an
absence of the abducens nerve and its corresponding
abducens nucleus in the pons, with abnormalities of the
lateral rectus muscle (which normally abducts the globe)
(Hotchkiss et al. 1980; Miller et al. 1982).
Individuals with the classic form of congenital fibrosis
of the extraocular muscles (CFEOM [MIM 135700]) are
born with bilateral ptosis and restrictive external
ophthalmoplegia, with their eyes partially or completely
fixed in an infraducted (downward) and strabismic po-
sition. This disorder is inherited in an autosomal dom-
inant fashion, and the causative gene has been mapped,
in multiple families, to the centromere of chromosome
12 (Engle et al. 1994, 1995). We now refer to the ex-
pression of this clinical phenotype in members of au-
tosomal dominant, fully penetrant pedigrees with genetic
linkage to 12cen as CFEOM1 (MIM 135700). Neuro-
pathological studies of an individual with CFEOM1 re-
vealed an absence of the superior division of the ocu-
lomotor nerve and its corresponding alpha motoneurons
in the midbrain, as well as marked abnormalities of the
two muscles that this branch innervates—the superior
rectus and the levator palpebrae superioris. These two
muscles elevate the globe and the eyelid, respectively,
and their functional absence results in the infraduction
and ptosis found in CFEOM1 (Engle et al. 1997b). These
findings suggest that the CFEOM1 and Duane syndrome
genes are essential for the normal development and/or
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axonal projection of a subset of human alpha moto-
neurons in the brain stem.
During the course of our studies, it became evident
that there were families with forms of CFEOM that dif-
fer phenotypically and genotypically from CFEOM1.
One of these variants is an autosomal recessive disorder
that we have characterized in three consanguineous Sa-
udi Arabian families. In contrast to the infraduction
found in CFEOM1 patients, most of the affected indi-
viduals in these kindreds are born with bilateral exotro-
pia and ptosis with the globes “frozen” in extreme ab-
duction. Although there are cases of isolated bilateral
restrictive exotropia or esotropia, referred to in the lit-
erature as “strabismus fixus” (Brown 1950; Apt and
Axelrod 1978; Harley et al. 1978), this is the first genetic
study of inherited restrictive exotropia. Here, we show
that this disorder, designated “CFEOM2” (MIM
602078), is not allelic to CFEOM1 and maps to a locus
on distal 11q13.
Subjects and Methods
Pedigree Collection
The families affected with CFEOM2 were identified,
and each participating individual signed a consent form
and was interviewed and examined by one or more of
the authors (J.Z., P.B.M., M.H.J., and/or A.A.). The
study was approved by and performed with institu-
tional-review-board approval from the King Khaled Eye
Specialist Hospital (KKESH [Riyadh]) and Children’s
Hospital (Boston).
DNA Typing
Blood samples were collected from 70 individuals (20
affected individuals) from the three families, and lym-
phocyte DNA was extracted by use of a standard pro-
tocol (Kunkel et al. 1977). Chromosomal analysis of
GTG-banded metaphase cells was performed on
lymphocytes of affected individuals Z IV:1 and Z IV:4.
Linkage studies employed DNA microsatellite mark-
ers (di-, tri-, and tetranucleotides) from the Cooperative
Human Linkage Center Human Screening Set/Weber
version 6 (Research Genetics). Linkage refinement was
conducted with additional markers from chromosomes
1 and 12, as described elsewhere (Engle et al. 1995,
1997a), as well as from Ge´ne´thon and other published
sources (Couillin et al. 1994; James et al. 1994; Dib et
al. 1996; Guru et al. 1997; Merscher et al. 1997). All
primer sequences are available from either Genome Da-
tabase or these publications. Primers were purchased
from Research Genetics, and Genosys Biotechnologies.
Amplification and analysis of each repeat polymorphism
were performed as reported elsewhere (Engle et al. 1994,
1995).
Linkage Analysis
LOD scores were calculated with the Fastlink version
3.0 package of programs (Lathrop and Lalouel 1984;
Lathrop et al. 1984; Cottingham et al. 1993; Scha¨ffer
et al. 1994), under the assumption of autosomal reces-
sive inheritance with full penetrance. Data on the pop-
ulation incidence of the mutation(s) are unavailable; for
purposes of LOD-score calculations, we used a disease
incidence of 1/1,000,000 births and 10 marker alleles
of equal frequency. Alteration of this incidence by
1,000-fold had negligible effects on the maximum
LOD scores.
Results
Clinical Description
The study is based on three Saudi Arabian fami-
lies—BD, BB, and Z—as shown in figures 1–3. Thirty-
seven members (9 affected) from pedigree BD, 24 mem-
bers (8 affected) from pedigree BB, and 9 members (3
affected) from pedigree Z participated in the study. In
all three families, the disorder is inherited as an auto-
somal recessive trait. There are two affected individuals
(BD IV:3 and BB IV:5) who have affected offspring, dem-
onstrating a pseudodominant inheritance pattern. Mem-
bers of each family identified loops of consanguinity re-
sulting from first-cousin marriages—one loop in Z, two
loops in BB, and six loops in BD. Pedigrees BD and BB
are from separate families/tribes within the same geo-
graphical area of eastern Saudi Arabia. Pedigree Z’s fam-
ily/tribe is from western Saudi Arabia and extends to
central Saudi Arabia. None of the families is aware of
an ancestral relationship to either of the other two.
A manuscript describing the clinical examinations and
surgical findings of the affected members of the three
families is in preparation (J. Zwann, P. B. Mullaney, M.
H. Jabak, and A. Al-Awad, unpublished data). In brief,
all affected individuals were born with nonprogressive
bilateral upper lid ptosis and restrictive ophthalmople-
gia. Most remarkably, in 18 of 20 affected individuals,
the globes were fixed in abduction with a ∼50–90-prism-
diopter exotropia bilaterally (fig. 4). In addition, 10 of
these individuals had much less remarkable deviations
in the vertical plane—6 (Z IV:1, BB V:12, BD V:4, BD
V:5, BD V:14, and BD VI:6) had mild unilateral hyper-
tropia, and 4 (BB IV:5, BB V:13, BD V:17, and BD V:
18) had mild unilateral hypotropia. Two of the 20 af-
fected individuals did not have exotropia: the eyes of
BD IV:3 were fixed in the neutral position; and the right
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Figure 1 Haplotype analysis of family BD, segregating CFEOM2. Blackened symbols denote those individuals who are clinically affected
with CFEOM 2; a diagonal slash (/) through a symbol denotes that the individual is deceased; a double horizontal line () denotes consanguinity;
and a plus sign () denotes that the individual participated in the study. Genotyping data and schematic haplotype bars for chromosome 11
markers are shown below the symbol for each individual and indicate regions of crossover. Gray-shaded bars denote disease-associated regions
of homozygosity within a family, and blackened bars denote subregions of haplotype identity between families. Horizontally hatched bars
highlight the inheritance of specific non–disease-associated haplotypes, and vertical lines denote noninformative regions adjacent to critical
recombination events.
eye of BB IV:5 was fixed in the neutral position, with
minimal residual down gaze, and the left eye was slightly
hypotropic with only mild limitation of horizontal gaze.
In all affected individuals, voluntary globe movements
were absent or consisted only of minimal residual ab-
duction, forced duction testing was positive (restricted),
and binocular vision was absent.
Most affected individuals had poor visual acuity, and
many had severe amblyopia, particularly in eyes in
which the pupil was covered by a ptotic lid (fig. 4). In
many of the older affected individuals, the pupils were
myotic and fixed or only sluggishly reactive to light or
pupillary dilators. Anterior segments were normal, and
the disks were normal or pale. Affected individuals BB
520 Am. J. Hum. Genet. 63:517–525, 1998
Figure 2 Haplotype analysis of family BB, segregating CFEOM2. Symbols are as defined in the legend to figure 1.
IV:5, BB V:13, and BB V:16 had extremely poor vision,
complete myosis, and electroretinogram (ERG) record-
ings that revealed a generalized reduction in amplitude.
Further ERG investigations are currently underway to
determine if these findings are independent or coinher-
ited with the fibrosis syndrome. Results of the remaining
cranial-nerve and general neurological examinations
were normal, although the affected children and some
affected adults appeared to have mild facial weakness.
Linkage of CFEOM2 to Distal Chromosome 11q13
Cytogenetic analysis of chromosomes from affected
individuals Z IV:1 and Z IV:4 appeared normal at 1400-
band level. The CFEOM1 locus on chromosome 12 (En-
gle et al. 1994, 1995) and the congenital ptosis locus on
chromosome 1 (Engle et al. 1997a) were analyzed, and
linkage was excluded at both loci as follows. At the 3-
cM critical region surrounding the CFEOM1 locus,
LOD scores !2.0 were obtained in pedigrees BB and
Z, at marker D12S61, with a recombination frequency
(v) of .08 and .05, and at markers D12S345 and
D12S1090, with and .04, respectively. A LODv  .07
score !2 was obtained in pedigree BD, at marker
D12S1668, with . At the 3-cM critical regionv  .11
surrounding the congenital ptosis locus, LOD scores
!2.0 were obtained in pedigrees BD, BB, and Z, at
marker D1S2134, with , .05, and .02, respec-v  .07
tively, and in pedigree Z, at markers D1S2733 and
D1S1616, with and .01, respectively. A ge-v  .03
nomewide search for linkage within family BD then was
performed, and 64 loci were ruled out successfully (data
not shown) before linkage to marker D11S2371, with
a LOD score of 5.8 at , was found (table 1).v  .05
Pedigrees BB and Z were then tested, and the disease
gene in these kindreds was shown to cosegregate with
D11S2371 (table 1).
To define the CFEOM2 critical region, additional
polymorphic markers in the region were tested for link-
age (table 1). On the basis of the structure and consan-
guinity loops found in the pedigrees, we hypothesized
that the mutation was introduced on a single allele by
individual I:1 or individual I:2 in families BD and Z and
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Figure 3 Haplotype analysis of family Z, segregating CFEOM2.
Symbols are as defined in the legend to figure 1.
Figure 4 Photograph of individual BB V:12, showing the clinical
features of CFEOM2. The toddler has bilateral ptosis and 60–80-
prism-diopter exotropia, right hypertropia, and marked limitation of
adduction, elevation, and depression. He fixes with his exotropic left
eye by deviating his head to the right and elevating his left lid with
his left index finger.
was likely to be on a common background within family
BB. We also considered it quite likely that the mutation
in all three families arose from a common founder in-
dividual. Therefore, we tested 44 polymorphic markers
between D11S1985 and D11S1321, in an attempt to
identify recombination events as well as regions of ho-
mozygosity within families and allelic association be-
tween families. This analysis revealed that, of the 44
markers, the distal 14 markers spanned the CFEOM2
critical region (figs. 1–3). Regions of overlapping ho-
mozygosity were identified within each family and, in
figures 1–3, are represented by the gray-shaded portions
of the schematic haplotype bars. In addition, within
these regions of homozygosity within each family, there
is a 3.6-cM subregion of haplotype identity found in all
nonrecombinant affected individuals of pedigrees BD
and BB. This shared disease-associated haplotype (1-1-
5-1-3-4-8-4-3) extends from D11S4139 to D11S2371
and, in figures 1 and 2, is highlighted as the blackened
portions of the haplotype bars. The affected members
of pedigree Z do not share with BD or BB a common
disease haplotype at the markers tested. The disease hap-
lotype shared between pedigrees BD and BB helps to
determine phase and to identify ancestral recombination
events. The recombination events within each family are
described below.
Pedigree BD.—Affected individuals V:5, V:14, and V:
17 share a region of allele homozygosity extending from
above D11S1337 to D11S2371 (data shown in fig. 1,
as gray-shaded/blackened haplotypes). Recombination
events between D11S4184/D11S1369 andD11S4207 in
affected individuals V:18 and VI:6, however, establish
D11S4207 as the telomeric flanking marker for the dis-
ease gene in this family. In addition, the disease alleles
carried by the two brothers IV:1 and IV:3 each contain
a centromeric recombination. This recombination occurs
between D11S4196 and D11S4162 in IV:1. Although
the Ge´ne´thon map places D11S4162 as 0.1 cM cen-
tromeric to D11S4196 (Dib et al. 1996), we have pro-
visionally reversed the order of these two markers, to
avoid the necessity of positing a double recombination
in individual IV:1. As a result, we refer to the flanking
centromeric marker as “D11S4196/D11S4162,” until
the markers are definitively ordered. Of note, tracing the
inheritance of an unaffected haplotype (shown, in fig. 1,
as horizontally hatched haplotypes) suggests that indi-
viduals III:3 and III:8 are related to their spouses, al-
though these relationships have not been determined. In
addition, our data support a spontaneous mutation of
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Table 1
Two-Point LOD Scores between the CFEOM2 Locus and 11q
Markers
MARKER
AND FAMILY
LOD SCORE AT v 
.00 .05 .10 .20 .30 .40
D11S4136:
BD  6.5 6.0 4.7 3.1 1.4
BB 1.4 3.0 2.8 2.1 1.2 .4
Z 2.6 2.4 2.1 1.5 1.0 .5
Total  11.9 10.9 8.3 5.3 2.3
D11S4139:
BD  6.3 5.8 4.4 2.8 1.2
BB 2.2 1.5 1.6 1.3 .8 .3
Z 1.1 1.0 .9 .7 .4 .2
Total  8.8 8.3 6.4 4.0 1.7
D11S4196:
BD  4.8 4.4 3.3 2.0 .7
BB 4.6 .6 .2 .1 .2 .2
Z 1.1 1.0 .9 .7 .4 .2
Total  5.2 5.1 4.1 2.6 1.1
D11S4162:
BD 9.5 8.5 7.6 5.6 3.5 1.4
BB .5 2.9 2.8 2.2 1.3 .5
Z 2.1 1.8 1.5 1.0 .5 .1
Total 11.1 13.2 11.9 8.8 5.3 2.0
D11S1314:
BD 7.1 6.4 5.7 4.1 2.6 1.1
BB 4.9 4.3 3.8 2.7 1.6 .6
Z .3 .2 .2 .1 .0 .0
Total 12.3 10.9 9.7 6.9 4.2 1.7
D11S4184:
BD 5.1 4.5 4.0 2.8 1.7 .8
BB 2.9 1.6 1.6 1.3 .7 .3
Z 1.2 1.1 1.0 .8 .5 .3
Total 3.4 7.2 6.6 4.9 2.9 1.4
D11S1369:
BD 5.8 5.2 4.7 3.5 2.3 1.1
BB 1.5 4.2 3.8 2.8 1.8 .7
Z 2.6 2.4 2.1 1.5 1.0 .5
Total 6.9 11.8 10.6 7.8 5.1 2.3
D11S4207:
BD  6.3 6.1 4.8 3.2 1.5
BB 1.5 4.2 3.8 2.8 1.7 .7
Z 4.4 .3 .5 .6 .4 .3
Total  10.8 10.4 8.2 5.3 2.5
D11S916:
BD  3.4 3.5 2.9 2.0 1.0
BB 1.5 4.2 3.8 2.8 1.7 .7
Z 2.4 2.2 1.9 1.4 1.0 .5
Total  9.8 9.2 7.1 4.7 2.2
D11S2371:
BD  5.8 5.5 4.3 2.7 1.1
BB 1.5 4.2 3.8 2.8 1.7 .7
Z 2.4 2.2 1.9 1.4 1.0 .5
Total  12.2 11.2 8.5 5.4 2.3
the non–disease-associated allele of marker D11S4136
in individual IV:1. This result was reproduced several
times and is the only spontaneous mutation found in the
study, and it does not influence the results. Thus, the
flanking markers for the CFEOM2 disease gene in ped-
igree BD are D11S4196/D11S4162 and D11S4207. The
maximum LOD score for pedigree BD is 9.5 ( ) andv  0
occurs at marker D11S4162 (table 1).
Pedigree BB.—Affected individual IV:5 and his two
affected sons (V:13 and V:16) share a region of homo-
zygosity extending from above D11S1337 to below
D11S1321 (shown, in fig. 2, as gray-shaded/blackened
haplotypes ). This disease haplotype was introduced into
the family not only by either I:1 or I:2 but also by II:4,
either II:5 or II:6, and IV:4, suggesting additional uni-
dentified loops of consanguinity. This disease haplotype
accounts for one of the two disease alleles in affected
individuals V:1, V:5, V:8, V:11, and V:12. The second
haplotype inherited by these five individuals contains a
centromeric recombination and, in all but V:1, a telo-
meric recombination. The centromeric recombination,
between D11S4196/D11S4162 and D11S1314, was
most likely introduced by II:1 (suggesting another uni-
dentified loop), since it is inherited by III:5 and IV:1. As
a result of this recombination, affected individual V:1
shares haplotype identity with V:13 and V:16, in the
region from D11S1314 through D11S1321. The telo-
meric recombination occurs between D11S1314 and
D11S4184/D11S1369 in unaffected individual IV:3.
Therefore, the paternally inherited disease allele of af-
fected individuals V:5, V:8, V:11, and V:12 defines the
centromeric and telomeric flanking markers for the
CFEOM2 gene as being D11S4162/D11S4162 and
D11S4184/D11S1369, respectively. The maximum
LOD score for pedigree BB is 4.9 ( ) and occurs atv  0
the single nonrecombinant marker, D11S1314 (table 1).
Pedigree Z.—Affected siblings IV:1, IV:4, and IV:6
share a region of homozygosity extending from above
D11S1337 to D11S1369 (shown, in fig. 3, as gray-
shaded haplotypes). A recombination event in individual
III:1, betweenD11S4184/D11S1369 andD11S4207, es-
tablishes D11S4207 as the telomeric flanking marker in
this family. The maximum LOD score obtainable in this
smaller pedigree is 2.6 ( ) and occurs at the maxi-v  0
mally informative markers, D11S4136 and D11S1369
(table 1).
Pooling the recombination data from each of the fam-
ilies results in the definition of an ∼2.5-cM critical region
for the CFEOM2 disease gene, a region that falls within
distal 11q13 (Merscher et al. 1997). The critical region
is flanked by D11S4196/D11S4162 and D11S4184/
D11S1369 (figs. 1–3 and table 1), and only one non-
recombinant marker, D11S1314, currently lies within it.
Discussion
Our data localize the causative gene for CFEOM2, an
exotropic variant of the congenital fibrosis syndromes,
to an ∼2.5-cM region on chromosome 11q13 flanked
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by polymorphic markers D11S4196/D11S4162 and
D11S4184/D11S1369. The marker order supported by
our linkage data is generally consistent with that pre-
viously published (James et al. 1994; Dib et al. 1996;
Merscher et al. 1997), although we provisionally have
reversed the order of D11S4196 and D11S4162. In ad-
dition, the CFEOM2-flanking telomeric marker remains
ambiguous, since D11S4184 and D11S1369 have not
been mapped relative to one another and cannot be or-
dered on the basis of our data.
The CFEOM2 critical region begins ∼6 cM telomeric
to D11S913 and the MEN1 region (Guru et al. 1997)
and may fall partially or completely within the 5.5-Mb
high-resolution integrated map of distal 11q13 con-
structed by Merscher et. al. (1997). Determining whether
D11S4184, D11S1314, and the CFEOM2-centromeric
recombinant markers fall within the 1,600 kb of the
Merscher map that are centromeric to D11S1369 will
better define the physical boundaries of the critical re-
gion. A physical map will provide the framework needed
to correctly order the flanking markers, to identify ad-
ditional polymorphic markers, and to allow us to include
or exclude four potential candidate genes mapped to
the region: KRN1, NUMA1, FOLR1, and FOLR2
(Merscher et al. 1997). In addition, since all three
CFEOM2 families are of similar ethnic and geographic
origin, all demonstrate consanguinity, and BD and BB
share a common disease-associated haplotype across the
critical region, it seems likely that their disorder arose
from a single founder mutation. Pedigree Z does not
share, at the markers studied, a common haplotype with
BD and BB; however, this family is from a different re-
gion of Saudi Arabia and may be more distantly related.
Therefore, there might be, around marker D11S1314, a
small region that displays a haplotype shared by all three
families. Generation of additional polymorphic markers
around D11S1314 will allow us to search for such a
region and to refine further the CFEOM2 locus by ho-
mozygosity mapping.
Autosomal recessive CFEOM has been reported pre-
viously in the Saudi Arabian population (Traboulsi et
al. 1993; Assaf 1997). However, to the best of our
knowledge, these families represent the most thoroughly
investigated group of patients with exotropic strabismus
fixus. Virtually all of the CFEOM2 individuals examined
have extreme exotropia with little or no deviation of the
globe in the vertical plane. Since the eyes of two affected
individuals are not horizontally deviated, however, bi-
lateral exotropia cannot be considered the defining fea-
ture of CFEOM2. Despite this, all affected members of
the three families are clinically distinguishable from in-
dividuals with CFEOM1, since none have significant bi-
lateral infraduction. CFEOM2 and CFEOM1 are ge-
netically distinguishable by their mode of inheritance
(recessive vs. dominant) and by the chromosomal lo-
calization of the mutated gene (11q13 vs. 12cen). The
population incidence of mutations in the CFEOM2 gene
is unknown, and it remains to be determined whether
additional patients will be identified. Once the CFEOM2
gene is cloned, it will be possible to look for pathogenic
mutations in those individuals with the more common,
sporadic exotropic strabismus fixus (Brown 1950; Apt
and Axelrod 1978; Harley et al. 1978), as well as in
patients with sporadic and, as yet, unclassified forms of
CFEOM.
The neuropathology underlying CFEOM2 has not
been elucidated. We hypothesize, however, that it may
be analogous to the defects found in individuals with
CFEOM1 and Duane syndrome and that it may result
from a selective absence of a pool of midbrain alpha
motoneurons and their corresponding axons. The ab-
normal development of the entire motor division of the
oculomotor (and, possibly, the trochlear) nucleus and/
or nerve would leave the abducens-innervated lateral
rectus muscle unopposed, resulting in ptosis and restric-
tive globe abduction. Thus, while CFEOM1 appears to
be due to a defect in the development of the superior
division of the oculomotor nerve, CFEOM2 is predicted
to result from a defect in the development of both its
superior and inferior branches.
There are many possible functions for the CFEOM1
and CFEOM2 genes, such as motoneuron growth and
differentiation factors and axonal navigation and path-
finding mediators. Theoretical candidates include such
molecules as the downstream targets of the Wnt-1 and
Engrailed-1 gene products, which are critical for the de-
velopment of oculomotor and trochlear motoneurons in
mice (Wurst et al. 1994; Fritzsch et al. 1995; Porter and
Baker 1997), and a relative of semaphorin III/D, which,
when knocked out in mice, results in errors of axonal
projection of cranial nerves V, VII, and IX–XI but not
of the oculomotor nerve (Taniguchi et al. 1997). Al-
though none of the currently known genes in the
CFEOM2 critical region are known to have similar func-
tion, they remain viable candidates on the basis of their
position, and it is likely that future studies will identify
additional transcription units in this region.
It has been recognized that there is a considerable
degree of homology between chromosome 11 and chro-
mosome 12. Examples of paralogous genes mapped to
chromosome 11 and chromosome 12, respectively, in-
clude insulinlike growth-factor 2 (IGF2) and insulinlike
growth-factor 1 (IGF1), parathyroid hormone (PTH)
and parathyroid hormone–like hormone (PTHLH), and
Harvey rat sarcoma viral oncogene homologue (HRAS)
and Kirsten rat sarcoma 2 viral oncogene homologue
(KRAS2) (OMIM). The members of each of these pairs
of genes share high degrees of homology, suggesting a
common evolutionary origin. Similarly, although they
come from regions of chromosome 11 and chromosome
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12 that have no known paralogous pairs of genes, the
CFEOM2 and CFEOM1 genes may well have parallel
functions in the development of the oculomotor axis.
Therefore, it is possible that they arose from a common
evolutionary origin and are homologous genes. If this is
true, then the identification of one may assist in the
cloning of the second.
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